Dublin, Oct. 11, 2017 -- The "Towards Natural Antimicrobials for Wound Dressings" report has been added to Research and Markets' offering.
This report will discuss the use of antibacterial wound dressings and currently used technical products for the treatment of infected wounds, the movement away from conventional noble metal usage to natural-origin antimicrobial products, and new advances in these technologies.
Contemporary commercial suppliers, products and processes will be outlined, and an introduction to new commercial and academic technologies will be given. Additionally, the continued use of silver as an antimicrobial agent will be evaluated and compared to newly engineered biocompatible particles and fibres.
With the ageing population and prevalence of cardiovascular disease and diabetes as well as increased number of surgeries (e.g. rthopaedics), a significant burden to the individuals, the healthcare system and the society as a whole is imposed. Consequently chronic wounds, ulceration and surgical wounds can cause patients pain and delayed healing if infection and biofilm formation on the surface of the wound develops.
On the other hand, with antibiotic-resistant bacteria, new viruses and hospital infections on the rise, a continuing need for managing and controlling infection in these wounds is anticipated to ensure the control of any threats to patient wellbeing and reduce patient treatment times related to infection.
Key Topics Covered:
1 Executive summary
2 Introduction
2.1 Optimal wound dressing properties
3 Antimicrobial agents
3.1 Definition
3.2 Mechanism of antimicrobials
3.3 Antimicrobials working within a textile dressing
3.4 The assessment of antimicrobial agents
4 Silver as an antimicrobial agent
4.1 Innovations in silver biocides
4.2 Controversies surrounding nano-particle silver
5 Commercial perspective
5.1 Current market antimicrobials wound dressing
6 Novel and natural antimicrobial agents
6.1 Honey
6.2 Chitosan
6.3 Curcumin
6.4 Sericin
6.5 Essential oils and plant extracts
6.6 Naturally occurring derivatives
6.7 Activated carbon
6.8 Other organic novel antimicrobials
6.9 Inorganic metal alternatives to silver
7 Antibacterial and fibre composites
7.1 Hydrofiber and hydrocolloid dressings (gel forming structures)
7.2 Bioactive wound materials
7.3 Electrospinning and nanostructures
8 Conclusion
9 References
List of Figures
Figure 1 Method of bacterial pick-up by Cutimed Sorbact
List of Tables
Table 1 Wound dressing function & properties
Table 2 Antimicrobial descriptive terms
Table 3 Contamination stages of a wound
Table 4 Test standards related to antimicrobial textiles (safety tests)
Table 5 Test standards related to antimicrobial textiles (performance tests - antibacterial testing)
Table 6 Antibacterial wound dressing available on the market
Companies Mentioned
- 3M Health Care
- Acelity
- Advancis Medical
- Aspen Medical Group
- BSN Medical
- Calgon Carbon
- Coloplast Pty Ltd
- ConvaTec
- Covidien
- Crawford Healthcare
- Derma Sciences Inc
- DermaRite
- Freudenberg
- Medline
- Mlnlycke Healthcare Ltd
- Paul Hartmann Ltd
- SanoMed Manufacturing
- Smith & Nephew
- Supreme Medical
- Systagenix Wound Management
For more information about this report visit https://www.researchandmarkets.com/research/qndj6c/towards_natural
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Wound Care


TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 



